Valeant Falls Below $80 for First Time in Two Years

(2:1econd)

A timeline of Valeant’s fall from the top

(1:32)

The Fall of Valeant Pharmaceuticals 2015

(7:35)

Checkmate or Stalemate: Valeant's fall from investing grace

(12:13)

The Valeant Fraud Explained

(11:27)

Valeant Pharmaceuticals in crosshairs of U.S. Congress

(2:30)

Valeant — spotting the dangers | Lex

(3:3)

The Rise and Fall of Valeant Pharmaceuticals: Business Case Study Explained

(7:28)

Valeant Scandal: How Valeant Scammed People Legally | Beyond Wonder

(4:31)

Valeant Suffers Biggest Drop on Record, What's Next?

(3:6)

The Lesson of Valeant: Don’t get caught up in the euphoria

(2:34)

Valeant CEO on Drug Price Hikes: We Made Mistakes

(1:49)

Key things investors need to know about Valeant | The Bottom Line

(2:19)

Valeant Shares Fall on Reports the Company May Sell Some Assets

(23)

The Astonishing Fall of Valeant Pharmaceuticals: A Modern Cautionary Tale

(49)

One Mutual Fund that Valeant Took Down with It

(4:58)

From Darling to Scandal: The Valeant Pharmaceuticals Story

(2:23)

Valiant - GodFada (Official Music Video)

(2:7)

Valeant: Damaged Goods or Deeply Discounted Drug Company?

(18:40)

Roddy Boyd on his investigative reporting on Valeant

(8:31)